Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap

摘要

Background: Opioid use disorder (OUD) is highly prevalent among justice-involved individuals. While risk for overdose and other adverse consequences of opioid use are heightened among this population, most justice involved individuals and other high-risk groups experience multiple barriers to engagement in opioid agonist treatment.